Hereditary spherocytosis (HS) has been a subject for studies of erythrocyte carbohydrate metabolism since 1954, when Selwyn and Dacie (1) observed that glucose corrected the increased lysis of HS erythrocytes incubated in autologous serum. Prankerd, Altman, and Young (2) reported abnormalities of incorporation of p32 into ATP 1 and 2,3-DPG with correction by adenosine. Tabechian, Altman, and Young (3) found the HS erythrocyte abnormally sensitive to inhibition of p32 uptake by sodium fluoride. These findings were interpreted as consistent with a defect in glycolysis, and enolase deficiency was specifically suggested (4). Recent studies of HS, however, have failed to confirm either an abnormality of phosphate partition (5, 6), or any deficiency in glycolytic enzymes (7). Thus, the relationship between erythrocyte carbohydrate metabolism and HS is still undefined. This paper reports the results of an evaluation of erythrocyte carbohydrate metabolism in HS by a different approach from that of previous studies.
Hereditary spherocytosis (HS) has been a subject for studies of erythrocyte carbohydrate metabolism since 1954, when Selwyn and Dacie (1) observed that glucose corrected the increased lysis of HS erythrocytes incubated in autologous serum. Prankerd, Altman, and Young (2) reported abnormalities of incorporation of p32 into ATP 1 and 2,3-DPG with correction by adenosine. Tabechian, Altman, and Young (3) found the HS erythrocyte abnormally sensitive to inhibition of p32 uptake by sodium fluoride. These findings were interpreted as consistent with a defect in glycolysis, and enolase deficiency was specifically suggested (4) . Recent studies of HS, however, have failed to confirm either an abnormality of phosphate partition (5, 6) , or any deficiency in glycolytic enzymes (7) . Thus 1 The following abbreviations are used: AMP, ADP, and ATP, adenosine mono-, di-, and triphosphate; IMP, inosine monoplhosphate; G-1-P, glucose-i-phosphate; G-6-P, glucose-6-phosphate; G-1,6-P, glucose-1,6-diphosphate; F-6-P, fructose-6-phosphate; F-1,6-P, fructose-1,6-diphosphate; G-3-P, glyceraldehyde-3-phosphate; 3-PG, 3- 
METHODS
The subjects of this study were 18 patients with HS, ten of whom had been splenectomized. The diagnosis of HS was defined by the usual criteria. The sl)lenectomized patients had normal peripheral blood values for hemoglobin, packed cell volume, and reticulocytes, except for an unexplained elevation of 4.4% reticulocytes in one patient. The hemoglobin values in the nonsplenectomized group varied from 8.3 to 12.8 g per 100 ml, and the percentage of reticulocytes, from 5.5 to 20.3. Control samples were obtained from volunteer physicians, students, and laboratory personnel.
Preparation of erythrocyte-plasma suspension. Fifty ml of blood was collected from fasting subjects in 5 mg of dry sodium heparin and centrifuged immediately for 15 minutes at 0 to 4' C and 700 g. The plasma, buffy coat, and approximately one-tenth the volume of packed erythrocytes were removed by aspiration. The procedure was repeated after reconstitution with the removed plasma. By this technique, the leukocyte concentration of the erythrocyte-plasma suspensions was reduced to less than 1,500 per mm', except in one splenectomized HS patient, where the count was 4,500. The reticulocyte content of the incubation suspensions never exceeded 2% for the splenectomized group.
Composition of incubation suspensions. A 9.6-ml volume of the prepared erythrocyte-plasma suspension was added to each of 3 Erlenmeyer flasks (25 ml). To each flask was added a) 1.4 ml of 15 mM phosphate Locke's solution, pH 7.4 (hereafter referred to as the "endogenous" suspension) or b) 1.4 ml of 0.02% methylene blue in Locke's solution or c) 1.4 ml of 0.02 M neutralized iodoacetic acid 2 in Locke's buffer solution. The suspensions were incubated in a Dubnoff shaker at 37' C adjusted to 90 to 100 oscillations per minute. The flasks were stoppered during the course of the experiment and opened only at 30-minute intervals to permit sampling. (Figure 1 ). Glucose was determined in barium hydroxide-zinc sulfate filtrates by the method of Somogyi (8) . ATP was determined in neutralized perchloric acid filtrates by the reduction of TPN mediated by glucose-6-phosphate dehydrogenase and hexokinase (9 (16) . The procedure depends on the fact that the phosphorus of 2,3-DPG resists 180 minutes of hydrolysis under the conditions employed. Other phosphate esters, however, resist hydrolysis to varying degrees, as shown in Table I , and a correction for their interference must be made should any of these esters vary appreciably during incubation. These corrections were applied as shown in Table II . Inorganic phosphate was determined by the method of Taussky and Shorr (17) .
The enzymatic assays of F-1,6-P and DHAP were made with a Beckman DU spectrophotometer and were based on the observed change in absorbance at 340 mAt in cuvettes containing 2 ml neutralized perchloric acid filtrate, 1 ml 0.08 M Tris buffer at pH 7.5, and 0.05 ml 0.003 M DPNH.3 The assay was initiated by the addition of 5 .d ca-glycerophosphate dehydrogenase,4 0.5 mg protein per ml, which yielded values for DHAP. After complete depletion of DHAP (approximately 10 minutes), F-1,6-P was determined by the addition of 20 pIA aldolase,4 1 mg protein per ml.
RESULTS
The results on normal and splenectomized subjects are summarized in Table III * Calculations were made as follows. Total resistant phosphorus equaled the difference between total phosphorus and the phosphorus released as inorganic phosphate by hydrolysis of trichloroacetic acid filtrates in 1 N sulfuric acid at 1000 C for 180 minutes. Combined pentose (assumed to be all nucleotide pentose) resistant phosphorus equaled the combined pentose phosphate multiplied by 0.71, the fraction of AMP or inosine monophosphate resistant to hydrolysis (Table I) . Ketose phosphate was assumed to be all diphosphate, and therefore its acid-resistant fraction equaled twice the micromolar change recorded in Table IV multiplied by 0.30 (Table I ). The sum of both resistant fractions thus calculated was then subtracted from the total resistant phosphorus, and this difference was divided by two to obtain the estimated micromolar changes in 2,3-DPG. No correction was applied for monophosphoglycerates. For composition of the incubation systems and for assay procedures employed, see Methods.
nectomized subjects in Table IV Glucose utilization in the presence of iodoacetate. Although the normal and HS erythrocytes had nearly the same rates of glucose utilization (and lactate production) in both the endogenous and methylene blue suspensions, different rates were observed in the iodoacetate suspensions (Table III). Glucose was utilized at only one-third the normal rate by HS erythrocytes. This observation was made in a system where the rate of glycolysis was considerably slowed by iodoacetate. The difference is quantitatively small, but statistically significant (p < 0.01).
The metabolism of pentose phosphates. Pentose phosphate changes were not significantly different between HS and normal erythrocytes in the endogenous and iodoacetate suspensions. There was, however, a striking difference observed under the influence of methylene blue (Figure 2) . In the normal erythrocytes, total pentose increased during most of the incubation period; in the HS erythrocyte, the increase was considerably less during the first 30 minutes, and then proceeded to decrease. The decreased accumulation of total pentose in the methylene blue suspension was found to be due almost entirely to a decrease in the fraction of bound pentose (combined in nucleoside and nucleotide forms). Free pentose phosphate was observed to rise during the initial 30 minutes of incubation, with a subsequent fall in concentration on further incubation in both HS and normal erythrocytes. Nucleoside and nutcleotide pentose did not rise during the incubation of the HS erythrocytes, in contrast to the progressive rise in concentration observed in normal erythrocytes, a rise due to nucleosides or nucleotides other than ATP. Although the changes observed represented less than 10% of the total pool of pentose-containing compounds, the differences were statistically significant (p < 0.01).
Metabolism of 2,3-DPG. There was a greater accumulation of 2,3-DPG in the endogenous HS cell suspension than in the normal cell suspension. This increase was statistically significant (p = 0.05). In the normal cell, the accumulation of 2,3-DPG in the endogenous system (0.04 umoles per ml erythrocytes; Table III) represented less than 1 % of the total concentration of 2,3-DPG (4.5 MAmoles per ml erythrocytes). In the HS cell, where the total concentration of 2,3-DPG was found to be normal, the increased accumulation of 2,3-DPG represented an increase of 7%o of the total concentration. In the methylene blue and iodoacetate systems, the metabolism of 2,3-DPG proceeded normally in the HS cell.
Alteration of pvyrtvate: lactate ratios by methyieue blute. In the methylene blue system, lactate production decreased, but pyruvate increased. Lactate was expected to decrease as glucose carbon was lost by CO, evolution. The increase in pyruvate, however, indicates that a deficiency in DPNH developed, preventing the conversion of some pyruvate to lactate. Such a deficiency could have occurred if there was an accelerated degradation of some of the lower 3-carbon metabolites leading to pyruvate, such as the degradation of 2,3-DPG in the iodoacetate system, but the degradation of these metabolites was not of sufficient magnitude in the methylene blue system to account for the considerable increase in pyruvate that took place (Table III) At present, the cause of the latter two observations is not clear. The ketose accumulating in the normal endogenous cell system consists principally of F-1,6-P apparently originating from a precursor other than glucose. The precursor s identity is unknown; we were unable to detect any accumulation of G-6-P in any of the incubation systems employed. Other possible precursors include G-1,6-P or glycogen. Bartlett (19, 20) has reported the presence of both of these compounds in normal erythrocytes. As for the increased sensitivity of the spherocyte to iodoacetate, a glycolytic inhibitor, others have shown the spherocyte to be abnormally sensitive to fluoride, also a glycolytic inhibitor (3) .
The inability of the spherocyte to accumulate combined pentose could have resulted from a decreased production of free pentose phosphate. The integrity of the hexose monophosphate shunt, however, by which free pentose phosphates can be produced, was unimpaired. The spherocyte oxidized a normal amount of glucose to pyruvate and lactate in the presence of methylene blue (Table  III) . Also, exploratory experiments in our laboratory showed that the rate of C1402 production from uniformly C14-labeled glucose in the presence of methylene blue was not significantly altered in HS erythrocytes. The unimpaired ability of the HS erythrocyte to produce free pentose phosphate is further shown by the data illustrated in Figure 2 ; during the first 30 minutes of incubation, the production of free pentose increased appreciably in the spherocyte, as it did in the normal erythrocyte.
An inability of the HS erythrocyte to utilize effectively the free pentose it produced could also explain its failure to form combined pentose. In that case, free rather than combined pentose might be expected to accumulate. The kinetic data of Figure 2 show no such accumulation. The two utilization curves for free pentose are not markedly dissimilar.
In view of the apparently normal production and utilization of free pentose, the failure of the HS erythrocyte to accumulate combined pentose when methylene blue is available is most likely a failure of some later reaction in the biosynthesis of a bound (nucleotide) pentose. The identity of that compound is unknown. It is unlikely to be ATP, which is effectively maintained at a normal level by the HS erythrocyte. Nor is it likely to be a pyridine nucleotide; Leder and Handler (21) have shown that variations in the concentration of pyridine nucleotides do not occur in the presence of methylene blue, and therefore their synthesis could not account for the increase in combined pentose that is discussed here.
None of the abnormalities reported for hereditary spherocytosis prevent the spherocyte from converting a normal quantity of glucose to lactate, or from maintaining a normal concentration of ATP. Also, the hexose monophosphate pathway is intact, and the significance of the pentose abnormality reported here remains to be established. This raises the question whether the intrinsic defect in the HS erythrocyte is primarily a defect in carbohydrate metabolism, or whether the metabolic abnormalities that we and others have observed are secondary to some other alteration. It is conceivable, for example, that an improperly constituted membrane could explain many of the abnormalities reported in hereditary spherocytosis; an alteration in permeability or of an active transport mechanism could upset the normal passage of fluoride, iodoacetate, and p32 into the cell, and could also produce the structural change in the spherocyte, with its increased osmotic fragility.
SUMMARY
Carbohydrate metabolism has been studied in erythrocytes of hereditary spherocytosis by the measurement of changing concentrations of metabolites in incubating plasma-erythrocyte suspensions, and modifications by the addition of methylene blue or iodoacetate have been evaluated. The most striking difference was the failure of pentose to accumulate in the methylene-blue-treated spherocyte. The possible mechanisms of this finding were discussed. Also, alterations in the metabolism of fructose diphosphate, 2,3-diphosphoglycerate, and dihydroxyacetone phosphate were observed, and there was an increased sensitivity to the inhibitory effects of iodoacetate.
